Schering-Plough
SGP
#508
Rank
ยฃ35.00 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Earnings for Schering-Plough (SGP.defunct.2009)

Earnings in 2008: ยฃ1.55 Billion

According to Schering-Plough's latest financial reports the company's current earnings are N/A. In 2008 the company made an earning of ยฃ1.55 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Schering-Plough from 1996 to 2008

Annual earnings

Year Earnings Change
2008ยฃ1.55 B
2006ยฃ1.12 B198.39%
2005ยฃ0.37 B-395.83%
2004-ยฃ0.13 Billion265.22%
2003-ยฃ34.87 Million-102.01%
2002ยฃ1.73 B3.62%
2001ยฃ1.67 B-5.39%
2000ยฃ1.77 B
1998ยฃ1.46 B22.34%
1997ยฃ1.19 B38.9%
1996ยฃ0.85 B